TUTOR: A MULTICENTER, PHASE 1 TRIAL OF TUCATINIB, TRASTUZUMAB, AND CAPECITABINE WITH STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES FROM HER-2 POSITIVE BREAST CANCER

被引：0
|
作者：
Ahluwalia, M. S. [1 ,2 ]
Ozair, A. [1 ,3 ]
Bardhan, M. [1 ]
Bellur, S. S. [1 ]
Perche, D. C. [1 ]
Starosciak, A. K. [1 ]
Khosla, A. A. [1 ]
Leon-Ariza, D. S. [1 ]
Rubens, M. [1 ]
Odia, Y. [1 ]
Mehta, M. P. [1 ,2 ]
Kotecha, R. R. [1 ,2 ]
McDermott, M. W. [2 ,4 ]
Leon, A. C. S. [1 ]
Mahtani, R. [1 ]
Peereboom, D. M. [5 ]
机构：
[1] Baptist Hlth South Florida, Miami Canc Inst, Miami, FL USA
[2] Florida Int Univ, Herbert Wertheim Coll Med, Miami, FL USA
[3] Univ Maryland Med, Dept Neurosurg, Baltimore, MD USA
[4] Baptist Hlth South Florida, Miami Neurosci Inst, Miami, FL USA
[5] Cleveland Clin, Cleveland, OH USA
来源：
NEURO-ONCOLOGY | 2024年 / 26卷
关键词：
D O I：
10.1093/neuonc/noae144.148
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P06.11.A
引用
收藏
页码：V47 / V47
页数：1
相关论文
共 50 条
  • [31] Role of trastuzumab in patients with brain metastases from Her2 positive breast cancer
    Bulut, Nilufer
    Harputluoglu, Hakan
    Dizdar, Omer
    Altundag, Kadri
    JOURNAL OF NEURO-ONCOLOGY, 2008, 86 (02) : 241 - 241
  • [32] Role of trastuzumab in patients with brain metastases from Her2 positive breast cancer
    Nilufer Bulut
    Hakan Harputluoglu
    Omer Dizdar
    Kadri Altundag
    Journal of Neuro-Oncology, 2008, 86 : 241 - 241
  • [33] Pegylated liposomal doxorubicin and trastuzumab in HER-2 overexpressing metastatic breast cancer: A multicenter phase II trial
    Chia, Stephen
    Clemons, Mark
    Martin, Lee-Ann
    Rodgers, Angela
    Gelmon, Karen
    Pond, Gregory R.
    Panasci, Lawrence
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 2773 - 2778
  • [34] Clinical efficacy of pyrotinib combined with stereotactic radiosurgery in HER2-positive breast cancer brain metastases.
    Zhen, Junjie
    Bashir, Shoaib
    Yang, Yanying
    Wang, Hui
    Lai, Mingyao
    Cai, Linbo
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [35] Sanctuary site leptomeningeal metastases in HER-2 positive breast cancer: A review in the era of trastuzumab
    Kordbacheh, T.
    Law, W. Y.
    Smith, I. E.
    BREAST, 2016, 26 : 54 - 58
  • [36] Trastuzumab (T) and CNS metastases in women with HER-2 positive metastatic breast cancer (MBC).
    Dawson, SJJ
    Ranieri, NF
    Snyder, RD
    McLachlan, SAA
    Burns, WI
    Newnham, GM
    Francis, PA
    Dowling, AJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 49S - 49S
  • [37] Updated Results of Tucatinib versus Placebo in Combination with Trastuzumab and Capecitabine in Patients with pretreated metastatic HER2-positive Breast Cancer with CNS Metastases (HER2CLIMB)
    Greil, R.
    Lin, U. N.
    Murthy, K. R.
    Abramson, V
    Anders, C.
    Bachelot, T.
    Bedard, L. P.
    Borges, V
    Cameron, D.
    Carey, L.
    Chien, J. A.
    Curigliano, G.
    DiGiovanna, P. M.
    Gelmon, K.
    Hortobagyi, G.
    Hurvitz, S.
    Krop, I
    Loi, S.
    Loibl, S.
    Mueller, V
    Oliveira, M.
    Paplomata, E.
    Pegram, M.
    Slamon, D.
    Zelnak, A.
    Ramos, J.
    Feng, W.
    Winer, E.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (04) : E4 - E5
  • [38] LAPATINIB AND CAPECITABINE IN THE TREATMENT OF HER2-POSITIVE BREAST CANCER WITH BRAIN METASTASES
    Dubianski, R.
    Brewczynska, E.
    Lemanska, I.
    Szombara, E.
    Nowecki, Z. I.
    ANNALS OF ONCOLOGY, 2014, 25
  • [39] Updated results of tucatinib vs placebo added to trastuzumab and capecitabine for patients with pretreated HER2+metastatic breast cancer with and without brain metastases (HER2CLIMB)
    Mueller, V
    Curigliano, G.
    Borges, V
    Hamilton, E.
    Hurvitz, S.
    Loi, S.
    Murthy, R.
    Okines, A.
    Paplomata, E.
    Cameron, D.
    Carey, L. A.
    Gelmon, K.
    Hortobagyi, G.
    Krop, I
    Loibl, S.
    Pegram, M.
    Slamon, D.
    Ramos, J.
    Feng, W.
    Winer, E.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 133 - 134
  • [40] Updated results of tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2+metastatic breast cancer with and without brain metastases (HER2CLIMB).
    Curigliano, Giuseppe
    Mueller, Volkmar
    Borges, Virginia F.
    Hamilton, Erika P.
    Hurvitz, Sara A.
    Loi, Sherene
    Murthy, Rashmi Krishna
    Okines, Alicia Frances Clare
    Paplomata, Elisavet
    Cameron, David A.
    Carey, Lisa A.
    Gelmon, Karen A.
    Hortobagyi, Gabriel N.
    Krop, Ian E.
    Loibl, Sibylle
    Pegram, Mark D.
    Slamon, Dennis J.
    Ramos, Jorge
    Zhang, Chiyu
    Winer, Eric P.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345